Hsa-miR-22-3p Inhibits Liver Cancer Cell EMT and Cell Migration/ Invasion by Indirectly Regulating SPRY2

Investigators demonstrated that miR-22 indirectly regulates SPRY2 by inhibiting CBL, an E3 ligase for SPRY2 that has been confirmed.